Multimillion-pound partnership breaks down barriers in MND research
Motor neuron disease (MND) is one of the most complex [...]
Metformin and nifedipine ruled out by EXPERTS-ALS drug-screening platform
An interim result from the EXPERTS-ALS trial shows neither drug [...]
New study identifies a genetic cause of MND in one in four people with the condition
A major international study has found that one in four [...]
New drug smilagenin to be evaluated through EXPERTS-ALS platform
A new candidate treatment for motor neuron disease (MND) will [...]
Neflamapimod to be evaluated through EXPERTS-ALS platform
A potential new treatment for motor neuron disease (MND) will [...]
Could biomarkers transform ALS clinical trials and accelerate treatment development?
A new systematic review highlights how biomarkers, biological indicators of [...]
Research snapshot: Slowed cell transport may signal early changes in MND
A new study has found that motor neuron disease (MND), [...]
Research snapshot: Could sleep changes signal the early stages of MND or FTD?
A new study has found that people who go on [...]
£7 million Longitude Prize on ALS launched to accelerate AI-driven drug discovery
A new international challenge prize has been launched to transform [...]
From discovery to treatment: How our translational research will find new treatments for MND
On MND Awareness Day, we’re spotlighting the projects accelerating real [...]
